INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

GRIMES & COMPANY, INC.'s Holding History (CIK: 0001321993)

Note: Option positions (PUT/CALL) are excluded.

Q4 2019
Shares 2,350 Value ($000) $291 Avg Close — Range —